Strategy

Unlocking value in pharma R&D

Read more

Raising the threshold: argenx predicts continued market expansion

Read more

Provincialism holds back Europe's biotech sector

Read more

Changes in the landscape for genome editing

Read more

A new therapeutic approach for IgA nephropathy

Read more

Swiss biotech helped by international deals, drug wins, By Jane Morrison

Read more

GLP-1 agonists shake up the sector

Read more

The quest for non-addictive chronic pain therapies

Read more

Treating hearing loss as people age

Read more

A regulatory win for a rare disease strategy

Read more